- call +1-201-465-4211
- email sales@mrinsights.biz
Pertussis vaccine is a vaccine that protects against whooping cough. There are two main types: whole-cell vaccines and acellular vaccines. The whole-cell vaccine is about 78% effective while the acellular vaccine is 71–85% effective.
Scope of the Report:
Manufacturers take the combination of direct Marketing channel and distribution sales in the form, Future sales channels both direct selling and distribution needs with the help of online sales platform.
The market channel is essential to every manufacturer and they are paying more and more attention to their channel building. Firstly, suppliers can build strong sales teams to directly manage their own customers. At the same time, more flexible and attractive channel incentives can be created and channel support can be provided in different ways. At the meantime, customers are concerning more on the product quality and services. So, except all of the distributors and direct marketing, they are also consider their logistics and services, making sure that both products and services are better than the competitors.
Depending on market position, make different pricing strategy. Pricing product is based on product position. Different kind of dispensers should be priced differently. It is obvious that high-end product should be expensive and low-end product should be cheap.
For the manufacturers, depreciate can bring more consumers and inflation can bring larger profit margin. When manufacturers price their products, should consider many factors like the manufacturing cost, market position and targets of price adjustment (larger profit margin, more consumers, larger market share, more order, etc.).
To build a brand admired by consumers need a long time, though the period is much shorter due to the development of advertising industry and internet. There are many ways to build a new brand, but only one way is always here, good product quality.
Today, brand strategy has been various. Some manufacturers hold their unique brand, which have been acquired by consumers. Exactly, consumers may prefer the known brand rather a new brand that they doesn’t know. On the contrary, some manufacturers may introduce several brands of their product. They featured each brand and market them for certain target client.
The worldwide market for Pertussis Vaccine is expected to grow at a CAGR of roughly xx% over the next five years, will reach xx million US$ in 2024, from xx million US$ in 2019, according to a new study.
This report focuses on the Pertussis Vaccine in global market, especially in North America, Europe and Asia-Pacific, South America, Middle East and Africa. This report categorizes the market based on manufacturers, regions, type and application.
Market Segment by Manufacturers, this report covers
Sanofi Pasteur
GSK
Mitsubishi Tanabe Pharma
Astellas Pharma
Minhai Biotechnology
Wuhan Institute of Biological Products
Changchun Changsheng Life Sciences
Market Segment by Regions, regional analysis covers
North America (United States, Canada and Mexico)
Europe (Germany, France, UK, Russia and Italy)
Asia-Pacific (China, Japan, Korea, India and Southeast Asia)
South America (Brazil, Argentina, Colombia etc.)
Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria and South Africa)
Market Segment by Type, covers
Whole-cell vaccines
Acellular vaccines
Market Segment by Applications, can be divided into
Children
Adults
The content of the study subjects, includes a total of 15 chapters:
Chapter 1, to describe Pertussis Vaccine product scope, market overview, market opportunities, market driving force and market risks.
Chapter 2, to profile the top manufacturers of Pertussis Vaccine, with price, sales, revenue and global market share of Pertussis Vaccine in 2017 and 2018.
Chapter 3, the Pertussis Vaccine competitive situation, sales, revenue and global market share of top manufacturers are analyzed emphatically by landscape contrast.
Chapter 4, the Pertussis Vaccine breakdown data are shown at the regional level, to show the sales, revenue and growth by regions, from 2014 to 2019.
Chapter 5, 6, 7, 8 and 9, to break the sales data at the country level, with sales, revenue and market share for key countries in the world, from 2014 to 2019.
Chapter 10 and 11, to segment the sales by type and application, with sales market share and growth rate by type, application, from 2014 to 2019.
Chapter 12, Pertussis Vaccine market forecast, by regions, type and application, with sales and revenue, from 2019 to 2024.
Chapter 13, 14 and 15, to describe Pertussis Vaccine sales channel, distributors, customers, research findings and conclusion, appendix and data source.
The base year for the study has been considered 2019, historic year 2014 and 2018, the forecast period considered is from 2020 to 2027. The regions analyzed for the market include North America, Europe, South America, Asia Pacific, and Middle East and Africa. These regions are further analyzed at the country-level. The study also includes attractiveness analysis of type, application and regions which are benchmarked based on their market size, growth rate and attractiveness in terms of present and future opportunity for understanding the future growth of the market.
Market is segmented on the basis:
The report offers in-depth analysis of driving factors, opportunities, restraints, and challenges for gaining the key insight of the market. The report emphasizes on all the key trends that play a vital role in the enlargement of the market from 2019 to 2026.
The report provides company profile of the key players operating in the market and a comparative analysis based on their business overviews industry offering, segment market share, regional presence, business strategies, innovations, mergers & acquisitions, recent developments, joint venture, collaborations, partnerships, SWOT analysis, and key financial information.
Table of Contents
1 Market Overview
1.1 Pertussis Vaccine Introduction
1.2 Market Analysis by Type
1.2.1 Whole-cell vaccines
1.2.2 Acellular vaccines
1.3 Market Analysis by Applications
1.3.1 Children
1.3.2 Adults
1.4 Market Analysis by Regions
1.4.1 North America (United States, Canada and Mexico)
1.4.1.1 United States Market States and Outlook (2014-2024)
1.4.1.2 Canada Market States and Outlook (2014-2024)
1.4.1.3 Mexico Market States and Outlook (2014-2024)
1.4.2 Europe (Germany, France, UK, Russia and Italy)
1.4.2.1 Germany Market States and Outlook (2014-2024)
1.4.2.2 France Market States and Outlook (2014-2024)
1.4.2.3 UK Market States and Outlook (2014-2024)
1.4.2.4 Russia Market States and Outlook (2014-2024)
1.4.2.5 Italy Market States and Outlook (2014-2024)
1.4.3 Asia-Pacific (China, Japan, Korea, India and Southeast Asia)
1.4.3.1 China Market States and Outlook (2014-2024)
1.4.3.2 Japan Market States and Outlook (2014-2024)
1.4.3.3 Korea Market States and Outlook (2014-2024)
1.4.3.4 India Market States and Outlook (2014-2024)
1.4.3.5 Southeast Asia Market States and Outlook (2014-2024)
1.4.4 South America, Middle East and Africa
1.4.4.1 Brazil Market States and Outlook (2014-2024)
1.4.4.2 Egypt Market States and Outlook (2014-2024)
1.4.4.3 Saudi Arabia Market States and Outlook (2014-2024)
1.4.4.4 South Africa Market States and Outlook (2014-2024)
1.4.4.5 Turkey Market States and Outlook (2014-2024)
1.5 Market Dynamics
1.5.1 Market Opportunities
1.5.2 Market Risk
1.5.3 Market Driving Force
2 Manufacturers Profiles
2.1 Sanofi Pasteur
2.1.1 Business Overview
2.1.2 Pertussis Vaccine Type and Applications
2.1.2.1 Product A
2.1.2.2 Product B
2.1.3 Sanofi Pasteur Pertussis Vaccine Sales, Price, Revenue, Gross Margin and Market Share (2017-2018)
2.2 GSK
2.2.1 Business Overview
2.2.2 Pertussis Vaccine Type and Applications
2.2.2.1 Product A
2.2.2.2 Product B
2.2.3 GSK Pertussis Vaccine Sales, Price, Revenue, Gross Margin and Market Share (2017-2018)
2.3 Mitsubishi Tanabe Pharma
2.3.1 Business Overview
2.3.2 Pertussis Vaccine Type and Applications
2.3.2.1 Product A
2.3.2.2 Product B
2.3.3 Mitsubishi Tanabe Pharma Pertussis Vaccine Sales, Price, Revenue, Gross Margin and Market Share (2017-2018)
2.4 Astellas Pharma
2.4.1 Business Overview
2.4.2 Pertussis Vaccine Type and Applications
2.4.2.1 Product A
2.4.2.2 Product B
2.4.3 Astellas Pharma Pertussis Vaccine Sales, Price, Revenue, Gross Margin and Market Share (2017-2018)
2.5 Minhai Biotechnology
2.5.1 Business Overview
2.5.2 Pertussis Vaccine Type and Applications
2.5.2.1 Product A
2.5.2.2 Product B
2.5.3 Minhai Biotechnology Pertussis Vaccine Sales, Price, Revenue, Gross Margin and Market Share (2017-2018)
2.6 Wuhan Institute of Biological Products
2.6.1 Business Overview
2.6.2 Pertussis Vaccine Type and Applications
2.6.2.1 Product A
2.6.2.2 Product B
2.6.3 Wuhan Institute of Biological Products Pertussis Vaccine Sales, Price, Revenue, Gross Margin and Market Share (2017-2018)
2.7 Changchun Changsheng Life Sciences
2.7.1 Business Overview
2.7.2 Pertussis Vaccine Type and Applications
2.7.2.1 Product A
2.7.2.2 Product B
2.7.3 Changchun Changsheng Life Sciences Pertussis Vaccine Sales, Price, Revenue, Gross Margin and Market Share (2017-2018)
3 Global Pertussis Vaccine Sales, Revenue, Market Share and Competition by Manufacturer (2017-2018)
3.1 Global Pertussis Vaccine Sales and Market Share by Manufacturer (2017-2018)
3.2 Global Pertussis Vaccine Revenue and Market Share by Manufacturer (2017-2018)
3.3 Market Concentration Rate
3.3.1 Top 3 Pertussis Vaccine Manufacturer Market Share in 2018
3.3.2 Top 6 Pertussis Vaccine Manufacturer Market Share in 2018
3.4 Market Competition Trend
4 Global Pertussis Vaccine Market Analysis by Regions
4.1 Global Pertussis Vaccine Sales, Revenue and Market Share by Regions
4.1.1 Global Pertussis Vaccine Sales and Market Share by Regions (2014-2019)
4.1.2 Global Pertussis Vaccine Revenue and Market Share by Regions (2014-2019)
4.2 North America Pertussis Vaccine Sales and Growth Rate (2014-2019)
4.3 Europe Pertussis Vaccine Sales and Growth Rate (2014-2019)
4.4 Asia-Pacific Pertussis Vaccine Sales and Growth Rate (2014-2019)
4.5 South America Pertussis Vaccine Sales and Growth Rate (2014-2019)
4.6 Middle East and Africa Pertussis Vaccine Sales and Growth Rate (2014-2019)
5 North America Pertussis Vaccine by Country
5.1 North America Pertussis Vaccine Sales, Revenue and Market Share by Country
5.1.1 North America Pertussis Vaccine Sales and Market Share by Country (2014-2019)
5.1.2 North America Pertussis Vaccine Revenue and Market Share by Country (2014-2019)
5.2 United States Pertussis Vaccine Sales and Growth Rate (2014-2019)
5.3 Canada Pertussis Vaccine Sales and Growth Rate (2014-2019)
5.4 Mexico Pertussis Vaccine Sales and Growth Rate (2014-2019)
6 Europe Pertussis Vaccine by Country
6.1 Europe Pertussis Vaccine Sales, Revenue and Market Share by Country
6.1.1 Europe Pertussis Vaccine Sales and Market Share by Country (2014-2019)
6.1.2 Europe Pertussis Vaccine Revenue and Market Share by Country (2014-2019)
6.2 Germany Pertussis Vaccine Sales and Growth Rate (2014-2019)
6.3 UK Pertussis Vaccine Sales and Growth Rate (2014-2019)
6.4 France Pertussis Vaccine Sales and Growth Rate (2014-2019)
6.5 Russia Pertussis Vaccine Sales and Growth Rate (2014-2019)
6.6 Italy Pertussis Vaccine Sales and Growth Rate (2014-2019)
7 Asia-Pacific Pertussis Vaccine by Country
7.1 Asia-Pacific Pertussis Vaccine Sales, Revenue and Market Share by Country
7.1.1 Asia-Pacific Pertussis Vaccine Sales and Market Share by Country (2014-2019)
7.1.2 Asia-Pacific Pertussis Vaccine Revenue and Market Share by Country (2014-2019)
7.2 China Pertussis Vaccine Sales and Growth Rate (2014-2019)
7.3 Japan Pertussis Vaccine Sales and Growth Rate (2014-2019)
7.4 Korea Pertussis Vaccine Sales and Growth Rate (2014-2019)
7.5 India Pertussis Vaccine Sales and Growth Rate (2014-2019)
7.6 Southeast Asia Pertussis Vaccine Sales and Growth Rate (2014-2019)
8 South America Pertussis Vaccine by Country
8.1 South America Pertussis Vaccine Sales, Revenue and Market Share by Country
8.1.1 South America Pertussis Vaccine Sales and Market Share by Country (2014-2019)
8.1.2 South America Pertussis Vaccine Revenue and Market Share by Country (2014-2019)
8.2 Brazil Pertussis Vaccine Sales and Growth Rate (2014-2019)
8.3 Argentina Pertussis Vaccine Sales and Growth Rate (2014-2019)
8.4 Colombia Pertussis Vaccine Sales and Growth Rate (2014-2019)
9 Middle East and Africa Pertussis Vaccine by Countries
9.1 Middle East and Africa Pertussis Vaccine Sales, Revenue and Market Share by Country
9.1.1 Middle East and Africa Pertussis Vaccine Sales and Market Share by Country (2014-2019)
9.1.2 Middle East and Africa Pertussis Vaccine Revenue and Market Share by Country (2014-2019)
9.2 Saudi Arabia Pertussis Vaccine Sales and Growth Rate (2014-2019)
9.3 Turkey Pertussis Vaccine Sales and Growth Rate (2014-2019)
9.4 Egypt Pertussis Vaccine Sales and Growth Rate (2014-2019)
9.5 Nigeria Pertussis Vaccine Sales and Growth Rate (2014-2019)
9.6 South Africa Pertussis Vaccine Sales and Growth Rate (2014-2019)
10 Global Pertussis Vaccine Market Segment by Type
10.1 Global Pertussis Vaccine Sales, Revenue and Market Share by Type (2014-2019)
10.1.1 Global Pertussis Vaccine Sales and Market Share by Type (2014-2019)
10.1.2 Global Pertussis Vaccine Revenue and Market Share by Type (2014-2019)
10.2 Whole-cell vaccines Sales Growth and Price
10.2.1 Global Whole-cell vaccines Sales Growth (2014-2019)
10.2.2 Global Whole-cell vaccines Price (2014-2019)
10.3 Acellular vaccines Sales Growth and Price
10.3.1 Global Acellular vaccines Sales Growth (2014-2019)
10.3.2 Global Acellular vaccines Price (2014-2019)
11 Global Pertussis Vaccine Market Segment by Application
11.1 Global Pertussis Vaccine Sales Market Share by Application (2014-2019)
11.2 Children Sales Growth (2014-2019)
11.3 Adults Sales Growth (2014-2019)
12 Pertussis Vaccine Market Forecast (2019-2024)
12.1 Global Pertussis Vaccine Sales, Revenue and Growth Rate (2019-2024)
12.2 Pertussis Vaccine Market Forecast by Regions (2019-2024)
12.2.1 North America Pertussis Vaccine Market Forecast (2019-2024)
12.2.2 Europe Pertussis Vaccine Market Forecast (2019-2024)
12.2.3 Asia-Pacific Pertussis Vaccine Market Forecast (2019-2024)
12.2.4 South America Pertussis Vaccine Market Forecast (2019-2024)
12.2.5 Middle East and Africa Pertussis Vaccine Market Forecast (2019-2024)
12.3 Pertussis Vaccine Market Forecast by Type (2019-2024)
12.3.1 Global Pertussis Vaccine Sales Forecast by Type (2019-2024)
12.3.2 Global Pertussis Vaccine Market Share Forecast by Type (2019-2024)
12.4 Pertussis Vaccine Market Forecast by Application (2019-2024)
12.4.1 Global Pertussis Vaccine Sales Forecast by Application (2019-2024)
12.4.2 Global Pertussis Vaccine Market Share Forecast by Application (2019-2024)
13 Sales Channel, Distributors, Traders and Dealers
13.1 Sales Channel
13.1.1 Direct Marketing
13.1.2 Indirect Marketing
13.1.3 Marketing Channel Future Trend
13.2 Distributors, Traders and Dealers
14 Research Findings and Conclusion
15 Appendix
15.1 Methodology
15.2 Data Source
List of Tables and Figures
Figure Pertussis Vaccine Picture
Table Product Specifications of Pertussis Vaccine
Figure Global Sales Market Share of Pertussis Vaccine by Types in 2018
Table
ProactiveWe manage our resources 24/7 to identify issues and address them before they become problems
Quality & ReliabilityWe are committed to providing reliable and highly accurate data with an excellent quality control system
Global Outreach6 Major regions and 40+ countries level analysis accomplished
Competitive PricingOur pricing strategy is highly competitive in the market, without compensating on the quality and the timeline of project delivery
